MedTrace Logo

Pulmonary Rehabilitation in Interstitial Lung Disease

NCT00168285 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2007-04-05

No results posted yet for this study

Summary

Interstitial lung disease (ILD) is a highly disabling group of conditions including idiopathic pulmonary fibrosis (IPF), acute and chronic interstitial pneumonias, connective tissue diseases and sarcoidosis. People with ILD frequently experience breathlessness on exertion, which limits their ability to undertake daily activities. People with ILD report very poor quality of life due to low levels of physical functioning and vitality, and high levels of breathlessness and fatigue. There are few treatments for ILD and those that are available have limited impact on quality of life.

The aim of this study is to assess the effects of Pulmonary Rehabilitation, which consists of specialised exercise training for people with lung disease, on exercise capacity and quality of life in people with ILD. We hypothesis that exercise training will result in reduced dyspnoea, improved exercise tolerance and enhanced quality of life.

Conditions

Interventions

BEHAVIORAL

Pulmonary Rehabilitation

Sponsors & Collaborators

  • La Trobe University

    collaborator OTHER

  • Austin Hospital, Melbourne Australia

    collaborator OTHER

  • Victorian Tuberculosis and Lung Association

    collaborator UNKNOWN

  • The Alfred

    lead OTHER

Principal Investigators

  • Anne E Holland, PhD · Alfred Hospital and LaTrobe University

  • Matthew Conron, MBBS · The Alfred

  • Prue Munro, BAppSc · The Alfred

  • Christine McDonald, MBBS PhD · Austin Hospital, Melbourne Australia

  • Catherine Hill, PhD · Austin Hospital, Melbourne Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Completion
2007-05-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168285 on ClinicalTrials.gov